Pipeline

Product & Indication Pre-Clinical Phase I Phase II Phase III FDA Approval
Intravenous citrulline Acute lung injury induced by CPB
Acute sickle cell crisis
Pre-Clinical Phase I Phase II Phase III FDA Approval
Product & Indication Intravenous citrulline
Acute lung injury induced by CPB
Acute sickle cell crisis